Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Services-Medical Laboratories

Standard Industrial Classification: SIC 8071

Industry Insider Sentiment Analysis

The Services-Medical Laboratories sector (SIC 8071) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2025-03-20 04:35 2025-03-17 NTRA Natera, Inc. Fesko John Officer SELL $146.04 795 $116,099 157,289
2025-03-20 04:00 2025-03-17 DGX QUEST DIAGNOSTICS INC PREVOZNIK MICHAEL E Officer SELL $170.00 4,643 $789,310 38,117
2025-03-19 00:27 2025-03-17 GH Guardant Health, Inc. Kalia Kumud Officer OPT+S $43.16 3,500 $151,060 19,720
2025-03-17 23:35 2025-03-14 FTRE Fortrea Holdings Inc. Morais Mark A. Officer OPT+S $9.70 1,207 $11,708 38,672
2025-03-17 23:33 2025-03-14 FTRE Fortrea Holdings Inc. Mcconnell Jill G. Officer OPT+S $9.70 1,210 $11,737 40,467
2025-03-17 23:37 2025-03-14 FTRE Fortrea Holdings Inc. Hanson James S. Officer OPT+S $9.70 1,007 $9,768 9,466
2025-03-14 23:32 2025-03-13 FTRE Fortrea Holdings Inc. Morais Mark A. Officer OPT+S $9.93 203 $2,016 35,596
2025-03-14 23:31 2025-03-13 FTRE Fortrea Holdings Inc. Mcconnell Jill G. Officer OPT+S $9.93 261 $2,592 37,394
2025-03-15 04:35 2025-03-14 NTRA Natera, Inc. Rabinowitz Matthew Director, Officer SELL $147.71 50,000 $7,385,250 2,365,415
2025-03-15 04:35 2025-03-12 NTRA Natera, Inc. Marcus Gail Boxer Director OPT+S $147.69 4,000 $590,773 9,704
2025-03-13 23:54 2025-03-12 FTRE Fortrea Holdings Inc. Morais Mark A. Officer OPT+S $9.98 499 $4,980 35,074
2025-03-13 23:53 2025-03-12 FTRE Fortrea Holdings Inc. Mcconnell Jill G. Officer OPT+S $9.98 643 $6,417 36,720
2025-03-12 23:06 2025-03-07 GRAL GRAIL, Inc. Ofman Joshua J. Officer SELL $31.20 2,109 $65,801 559,673
2025-03-12 23:04 2025-03-07 GRAL GRAIL, Inc. Freidin Aaron Officer SELL $31.20 1,816 $56,659 335,170
2025-03-12 23:07 2025-03-07 GRAL GRAIL, Inc. RAGUSA ROBERT P Director, Officer SELL $31.21 7,625 $237,976 828,662
2025-03-12 23:30 2025-03-10 CDNA CareDx, Inc. Bickerstaff George Director SELL $18.36 20,000 $367,102 103,027
2025-03-12 04:31 2025-03-07 RDNT RadNet, Inc. SWARTZ DAVID L Director SELL $50.84 25,000 $1,271,000 174,067
2025-03-11 23:07 2025-03-07 CSTL CASTLE BIOSCIENCES INC MAETZOLD DEREK J Director, Officer SELL $20.07 29,177 $585,673 78,335
2025-03-11 00:26 2025-03-07 SERA SERA PROGNOSTICS, INC. Lindgardt Zhenya Director, Officer SELL $4.12 29,722 $122,455 876,657
2025-03-11 00:25 2025-03-07 SERA SERA PROGNOSTICS, INC. Aerts Austin Officer SELL $4.12 4,818 $19,850 309,702
2025-03-11 00:26 2025-03-07 SERA SERA PROGNOSTICS, INC. Harrison Robert Gardner Officer SELL $4.16 3,874 $16,116 121,757
2025-03-10 23:43 2025-03-07 VCYT VERACYTE, INC. Leite John Officer SELL $31.66 7,411 $234,629 100,249
2025-03-08 03:18 2025-03-05 RDNT RadNet, Inc. Wesdorp Cornelis Officer SELL $51.63 5,000 $258,140 55,995
2025-03-08 05:35 2025-03-05 NTRA Natera, Inc. Moshkevich Solomon Officer SELL $143.29 6,000 $859,734 143,768
2025-03-08 05:35 2025-03-05 NTRA Natera, Inc. Chapman Steven Leonard Director, Officer SELL $143.40 87,272 $12,515,006 203,354
2025-03-08 03:30 2025-03-06 SERA SERA PROGNOSTICS, INC. Mirza Mansoor Raza Director SELL $4.16 99 $412 43,885
2025-03-08 03:29 2025-03-06 SERA SERA PROGNOSTICS, INC. Kearney Paul Officer SELL $4.16 1,338 $5,566 203,800
2025-03-08 03:29 2025-03-06 SERA SERA PROGNOSTICS, INC. Jackson Benjamin Officer SELL $4.16 2,285 $9,506 138,544
2025-03-08 03:28 2025-03-06 SERA SERA PROGNOSTICS, INC. Boniface John J. Officer SELL $4.16 2,044 $8,503 170,850
2025-03-08 03:28 2025-03-06 SERA SERA PROGNOSTICS, INC. Aerts Austin Officer SELL $4.16 540 $2,246 314,520
2025-03-08 03:29 2025-03-06 SERA SERA PROGNOSTICS, INC. Harrison Robert Gardner Officer SELL $4.16 3,251 $13,524 125,631
2025-03-07 16:16 2025-03-05 LH LABCORP HOLDINGS INC. ANDERSON KERRII B Director SELL $255.63 500 $127,817 13,166
2025-03-08 03:23 2025-03-05 DGX QUEST DIAGNOSTICS INC Doherty Catherine T. Officer SELL $174.13 5,370 $935,078 68,068
2025-03-07 00:30 2025-03-05 GRAL GRAIL, Inc. Freidin Aaron Officer SELL $41.51 521 $21,627 336,986
2025-03-07 00:28 2025-03-05 GRAL GRAIL, Inc. Ofman Joshua J. Officer SELL $41.51 525 $21,793 561,782
2025-03-07 00:42 2025-03-04 VCYT VERACYTE, INC. Febbo Phillip G. Officer SELL $33.35 8,037 $268,013 82,540
2025-03-07 00:41 2025-03-04 VCYT VERACYTE, INC. Stapley Marc Director, Officer SELL $33.34 52,697 $1,756,855 268,035
2025-03-07 00:41 2025-03-04 VCYT VERACYTE, INC. McGuire Annie Officer SELL $33.69 1,142 $38,476 70,308
2025-03-07 00:17 2025-03-04 CSTL CASTLE BIOSCIENCES INC MAETZOLD DEREK J Director, Officer OPT+S $20.86 5,687 $118,619 4,935
2025-03-07 00:27 2025-03-05 GRAL GRAIL, Inc. RAGUSA ROBERT P Director, Officer SELL $41.51 994 $41,261 836,287
2025-03-06 00:48 2025-03-03 GH Guardant Health, Inc. Joyce Meghan V. Director OPT+S $42.71 100 $4,271 7,647
2025-03-06 02:47 2025-03-05 FLGT Fulgent Genetics, Inc. Kim Paul Officer BUY $15.96 100,000 $1,596,470 348,282
2025-03-06 00:38 2025-03-04 DGX QUEST DIAGNOSTICS INC Doherty Catherine T. Officer SELL $175.79 716 $125,866 68,068
2025-03-06 00:35 2025-03-04 DGX QUEST DIAGNOSTICS INC PREVOZNIK MICHAEL E Officer SELL $175.79 592 $104,068 38,117
2025-03-04 16:41 2025-02-28 LH LABCORP HOLDINGS INC. Schroeder Mark S Officer OPT+S $249.23 5,339 $1,330,639 4,960
2025-03-04 00:30 2025-02-27 VCYT VERACYTE, INC. Leite John Officer SELL $33.84 5,746 $194,445 79,070
2025-03-01 05:05 2025-02-26 NTRA Natera, Inc. Sheena Jonathan Director SELL $160.50 5,700 $914,873 43,282
2025-03-01 00:38 2025-02-27 DGX QUEST DIAGNOSTICS INC PREVOZNIK MICHAEL E Officer SELL $172.61 528 $91,138 39,031
2025-03-01 00:35 2025-02-27 DGX QUEST DIAGNOSTICS INC Doherty Catherine T. Officer SELL $172.61 824 $142,231 69,178
2025-02-27 18:07 2025-02-25 LH LABCORP HOLDINGS INC. van der Vaart Sandra D Officer SELL $251.30 1,314 $330,208 2,171
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Services-Medical Laboratories sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8071) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Services-Medical Laboratories

Every transaction in the Services-Medical Laboratories industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.